Screening and identification of lung cancer metastasis-related genes by suppression subtractive hybridization

Thoracic Cancer

Volumn 3, Issue 3, 2012, Pages 207-216

  Liu, Jiewei ^a,b   Zhong, Xiaorong ^b   Li, Juan ^b   Liu, Baoxing ^a   Guo, Shanxian ^b   Chen, Jun ^b   Tan, Qingwei ^c   Wang, Qin ^c   Ma, Wei ^b   Wu, Zhihao ^b   Wang, Haisu ^b   Hou, Mei ^a   Zhang, Hong Tao ^d   Zhou, Qinghua ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c DALIAN MEDICAL UNIVERSITY   (China)

^d MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

ACTG1; AKR1B1; ANXA2; Cancer metastasis; Lung cancer; Suppression subtractive hybridization

Indexed keywords

ACTIN; ALDEHYDE REDUCTASE; ANTIOXIDANT; COMPLEMENTARY DNA; GAMMA ACTIN; LIPOCORTIN 2; RHO FACTOR; RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE REPRESSION; GENETIC TRANSCRIPTION; HEREDITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; METASTASIS; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; UPREGULATION; WESTERN BLOTTING;

EID: 84864752846     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/j.1759-7714.2011.00092.x     Document Type: Article

References (37)

1. Inamura K, Ishikawa Y. Lung cancer progression and metastasis from the prognostic point of view. Clin Exp Metastasis 2010; 27: 389-97.
2. Xu Y, Liu HY, Chen J, Zhou QH. Comparisons between the National Comprehensive Cancer Network (NCCN) non-small-cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009. Thorac Cancer 2010; 1: 83-6. DOI 10.1111/j.1759-7714.2010.00016.x.
3. Yang XQ, You JC, Zhou QH etal. The N-terminal kinase suppressor of Ras complex has a weak nucleoside diphosphate kinase activity. Thorac Cancer 2010; 1: 109-15. DOI 10.1111/j.1759-7714.2010.00020.x.
4. Tseng JJ, Chou MM. Differential expression of growth-, angiogenesis- and invasion-related factors in the development of placenta accreta. Taiwan J Obstet Gynecol 2006; 45: 100-6.
5. Kumar R, Xi YG. MicroRNA, epigenetic machinery and lung cancer. Thorac Cancer 2011; 2: 35-44. DOI 10.1111/j.1759-7714.2011.00043.x.
6. Diatchenko L, Lau YF, Siebert PD etal. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A 1996; 93: 6025-30.
7. Cao W, Epstein C, Asher Z etal. Comparing gene discovery from Affymetrix GeneChip microarrays and Clontech PCR-select cDNA subtraction: a case study. BMC Genomics 2004; 5: 26.
8. Huang X, Li Y, Niu Q, Zhang K. Suppression Subtractive Hybridization (SSH) and its modifications in microbiological research. Appl Microbiol Biotechnol 2007; 76: 753-60.
9. Zhou Q, Wang Y, Che G etal. Establishment and their biological characteristics of clonal cell subpopulations (NL9980 and L9981) from a human lung large cell carcinoma cell ling (WCQH-9801). Zhongguo Fei Ai Za Zhi 2003; 6: 464-8.
10. Sharma M, Ownbey RT, Sharma MC. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Exp Mol Pathol 2010; 88: 278-86.
11. Zhang Y, Hu MY, Liu KD etal. The effects of ezrin on the proliferation and the invasiveness of cells of different hepatocellular carcinoma cell lines. Zhonghua Gan Zang Bing Za Zhi 2006; 14: 489-94.
12. Tammali R, Ramana KV, Singhal SS, Awasthi S, Srivastava SK. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells. Cancer Res 2006; 66: 9705-13.
13. Ditzel HJ, Strik MCM, Jensenius JC etal. Cancer-associated cleavage of cytokeratin 8/18 heterotypic complexes exposes a neoepitope in human adenocarcinomas. J Biol Chem 2002; 277: 21712-22.
14. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev 2002; 82: 331-71.
15. Habets GGM, Scholtes EHM, Collard JG etal. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 1994; 77: 537-49.
16. Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA- dependent plasminogen activation. J Biol Chem 1994; 269: 21198-203.
17. Sarafian T, Pradel LA, Henry JP, Aunis D, Bader MF. The participation of annexin II (calpactin I) in calcium-evoked exocytosis requires protein kinase C. J Cell Biol 1991; 114: 1135-47.
18. Zobiack N, Rescher U, Ludwig C, Zeuschner D, Gerke V. The annexin 2/S100A10 complex controls the distribution of transferrin receptor-containing recycling endosomes. Mol Biol Cell 2003; 14: 4896-908.
19. Babiychuk EB, Monastyrskaya K, Burkhard FC, Wray S, Draeger A. Modulating signaling events in smooth muscle: cleavage of annexin 2 abolishes its binding to lipid rafts. FASEB J 2002; 16: 1177-84.
20. Benaud C, Gentil BJ, Assard N etal. AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture. J Cell Biol 2003; 164: 133-144.
21. Okuse K, Malik-Hall M, Baker MD etal. Annexin II light chain regulates sensory neuron-specific sodium channel expression. Nature 2002; 417: 653-6.
22. Kwon M, MacLeod TJ, Zhang Y, Waisman DM. S100A10, annexin A2, and annexin A2 heterotetramer as candidate plasminogen receptors. Front Biosci 2005; 10: 300-25.
23. Mai J, Waisman DM, Sloane BF. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim Biophys Acta 2000; 1477: 215-30.
24. Wirl G, Schwartz-Albiez R. Collagen-binding proteins of mammary epithelial cells are related to Ca2(+)- and phospholipid-binding annexins. J Cell Physiol 1990; 144: 511-22.
25. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994; 269: 21191-7.
26. Choi KS, Ghuman J, Kassam G, Kang HM, Fitzpatrick SL, Waisman DM. Annexin II tetramer inhibits plasmin-dependent fibrinolysis. Biochemistry 1998; 37: 648-55.
27. Ohno Y, Izumi M, Kawamura T, Nishimura T, Mukai K, Tachibana M. Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Br J Cancer 2009; 101: 287-94.
28. Zhao P, Zhang W, Tang J etal. Annexin II promotes invasion and migration of human hepatocellular carcinoma cells invitro via its interaction with HAb18G/CD147. Cancer Sci 2010; 101: 387-95.
29. Shiozawa Y, Havens AM, Taichman RS etal. Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J Cell Biochem 2008; 105: 370-80.
30. Yao H, Zhang Z, Chen Z etal. Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer 2009; 65: 41-8.
31. Yan H, Rivkees SA. Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J Neurosci Res 2002; 69: 597-606.
32. Jeong HC, Kim GI, Chung KH etal. Proteomic analysis of human small cell lung cancer tissues: up-regulation of coactosin-like protein-1. J Proteome Res 2011; 10: 269-76.
33. Li Y, Liang Q, Li Z etal. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone. Cancer Genet Cytogenet 2010; 198: 97-106.
34. Saraswat M, Mrudula T, Geereddy BR etal. Overexpression of aldose reductase in human cancer tissues. Med Sci Monit 2006; 12: CR525-529.
35. Tammali R, Ramana KV, Srivastava SK. Aldose reductase regulates TNF-alpha-induced PGE2 production in human colon cancer cells. Cancer Lett 2007; 252: 299-306.
36. Dan S, Shirakawa M, Yamori T etal. Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines. Cancer Sci 2003; 94: 1074-82.
37. Plebuch M, Soldan M, Hungerer C, Koch L, Maser E. Increased resistance of tumor cells to daunorubicin after transfection of cDNAs coding for anthracycline inactivating enzymes. Cancer Lett 2007; 255: 49-56.